Lexicon Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
Browse to the bottom of this webpage for potential risks for Lexicon Pharmaceuticals Inc based on sector, location and marketcap. The article includes a Q&A table on Lexicon Pharmaceuticals Inc. This assessment of Lexicon Pharmaceuticals Inc is assembled by All Street Sevva using proprietary machine learning.
Lexicon Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.8; made up of an environmental score of 2.0, social score of 3.2 and governance score of 3.2.
2.8
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1353 | Vera Therapeutics Inc | 2.9 | Medium |
1353 | Veracyte Inc | 2.9 | Medium |
1393 | Lexicon Pharmaceuticals Inc | 2.8 | Medium |
1393 | Bioventix PLC | 2.8 | Medium |
1393 | Bolt Biotherapeutics Inc | 2.8 | Medium |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |
Frequently Asked Questions
Does Lexicon Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Lexicon Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Lexicon Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Lexicon Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Lexicon Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Lexicon Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Lexicon Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Lexicon Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Lexicon Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Lexicon Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Lexicon Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Lexicon Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Lexicon Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Lexicon Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Lexicon Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Lexicon Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Lexicon Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Lexicon Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Lexicon Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Lexicon Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Lexicon Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Lexicon Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Lexicon Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Lexicon Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Lexicon Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Lexicon Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Lexicon Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Lexicon Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Lexicon Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Lexicon Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Lexicon Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Lexicon Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Lexicon Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Lexicon Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Lexicon Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Lexicon Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Lexicon Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain. The company has strategic collaboration and license agreements with Bristol-Myers Squibb Company, and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in The Woodlands, Texas.